Related Experiment Video
Updated: Aug 18, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Angiotensin-receptor blockers and diuretics--advantages of combination
1Department of Medicine, University of Montpellier, Montpellier, France. amimran@wanadoo.fr
Insights
Many patients have uncontrolled hypertension, increasing cardiovascular risks. Combining an angiotensin-receptor blocker (ARB) with a thiazide diuretic offers effective blood pressure control and tolerability, especially for those with poor response to single-drug therapy.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Hypertension affects millions, with many patients failing to reach target blood pressure (BP) levels.
- Uncontrolled hypertension significantly elevates risks for stroke, heart failure, myocardial infarction, and target-organ damage.
- Strict BP control is crucial for reducing cardiovascular events, often necessitating multiple antihypertensive agents.
Purpose of the Study:
- To evaluate the efficacy and tolerability of combining an angiotensin-receptor blocker (ARB) with a thiazide diuretic for hypertension management.
- To identify patient populations that may particularly benefit from this combination therapy.
Main Methods:
- This study focuses on the synergistic effects of ARBs and thiazide diuretics in blood pressure reduction.
- The research reviews data on the complementary actions of these drug classes on left ventricular hypertrophy and renal disease progression.
- Tolerability profiles of the combined therapy are assessed.
Main Results:
- The combination of an ARB and a thiazide diuretic demonstrates complementary effects beneficial for blood pressure reduction.
- This combination therapy shows promise in managing left ventricular hypertrophy and slowing the progression of renal diseases.
- The combined ARB and thiazide diuretic approach offers excellent tolerability.
Conclusions:
- Combining an ARB with a thiazide diuretic is an effective strategy for achieving target blood pressure control in many hypertensive patients.
- This combination therapy is particularly valuable for patients with resistant hypertension or additional cardiovascular and renal risk factors.
- The favorable tolerability profile further supports the use of ARB and thiazide diuretic combinations in clinical practice.
Abstract:
Surveys have shown that in as many as half of patients treated for hypertension, blood pressure (BP) is not controlled to target levels; many more persons have undertreated hypertension. Uncontrolled hypertension is a serious risk factor for cardiovascular events such as stroke, heart failure, myocardial infarction and target-organ diseases. Studies have shown that strict BP control significantly reduces the occurrence of these cardiovascular outcomes, in the majority of patients, effective BP control requires two or more antihypertensive agents. The combination of an angiotensin-receptor blocker (ARB) and a thiazide diuretic is appealing, since these agents have complimentary effects on BP reduction, left ventricular hypertrophy and progression of renal diseases. In addition, this combination provide excellent tolerability. The combination of an ARB and a thiazide diuretic may be of particular value in patient populations who tend to have poor BP control on monotherapy, or have additional cardiovascular or renal risk factors.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Action of Diuretics